In conclusion, our results indicate that changes in inflammatory biomarkers (plasma MMP9 and TNFα) associated with breast cancer risk and survival in breast cancer survivors with low plasma 25(OH)D levels, supplemented with vitamin D3 depends on VDR SNPs (Cdx2, TaqI and BsmI) and haplotypes. The gene discussed is CDX2; the disease is breast cancer.